PubMed HealthSearch

PubMed · 7416656

The hepatitis knowledge base. A prototype information transfer system.

Abstract

The Hepatitis Knowledge Base is a prototype computerized information-transfer system aimed at supporting the health practitioner's day-to-day diagnosis, prognosis, and treatment decisions concerned with viral hepatitis. An overview of information-transfer problems in biomedicine is presented and issues pertinent to the knowledge-base concept are discussed. The following research activities are described: selection and organization of the content of the initial draft of the complete Hepatitis Knowledge Base; the method for consensus development by a nationally distributed panel of collaborating experts on the subject matter; methods for updating the knowledge base and maintaining its currency over time; use of a computer conferencing network as the principal medium of communication among the geographically dispersed experts and the project staff; support of on-line access to the knowledge-base contents; and formative evaluation of the above methods and limited field testing of the access system.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L M Bernstein, E R Siegel, C M Goldstein. 1980. The hepatitis knowledge base. A prototype information transfer system.. https://doi.org/10.7326/0003-4819-93-1-169

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Extra-hepatic manifestations of viral hepatitis].

A variety of prodromal symptoms of viral hepatitis (urticaria, fever, arthralgias, headache, polyradiculonevritis) are attributed to A, B, C, D or E hepatitis only when jaundice appears, and because they disappear with it. Spectacular extrahepatic symptoms (polyarteritis nodosa, cryoglobulinemia, glomerulonephritis, marrow aplasia...) may be associated with B or C hepatitis without any liver symptom. Some of the extrahepatic symptoms observed during chronic hepatitis C therapy with interferon (thyroid dysfunctions, cutaneo-mucous lichen) may be related to the immunomodulatory effects of interferon rather than to virus C itself.

Hepatitis, Viral, Human

Development of antiviral therapy with alpha interferons: promises, false hopes and accomplishments.

This overview describes the development of interferon therapy in four different types of viral diseases. (1) Upper respiratory infections: despite extensive efforts interferons have not found a place in the treatment of these very common diseases. (2) Herpes keratitis: alpha interferons are highly active in combination therapy, but have gained only very limited clinical use. (3) Papillomavirus infections: alpha interferons have been approved for the treatment of papillomavirus infections of skin and mucous membranes and are in fairly wide clinical use. (4) Chronic hepatitis B, C and D: alpha interferons have become the treatment of choice and are used very extensively worldwide. The four examples illustrate both the clinical potentials and the limitations of alpha interferons and give some guidelines for future work. The overall conclusion is that chronic viral diseases lend themselves to interferon therapy more readily than acute viral infections. The general trend is toward the use of interferons in combination therapy.

Hepatitis, Viral, Human